Julie Brull
Nurse Practitioner · Hays, KSNPI 1538278429
Payments from drug & device makers
Across 189 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$779
- Johnson & Johnson$670
- E.r. Squibb & Sons, L.L.C.$380
- Sun Pharmaceutical Industries Inc.$333
- Novartis$286
- Amgen$182
- plus $530 from 12 others
What the payments were for
- Food & beverage$2,72786%
- Education$43214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $779 |
| Johnson & Johnson | 26 | $670 |
| E.r. Squibb & Sons, L.L.C. | 29 | $380 |
| Sun Pharmaceutical Industries Inc. | 11 | $333 |
| Novartis | 18 | $286 |
| Amgen | 11 | $182 |
| Pfizer | 9 | $140 |
| Organon | 6 | $101 |
| LEO Pharma Inc. | 4 | $56 |
| UCB, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Genentech USA, Inc. | 4 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| Biowound Solutions, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $18 |
| Incyte Corporation | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$3,159 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 379 | $3,705 |
| Fluocinonide | 84 | $3,520 |
| Betamethasone Dipropionate | 50 | $2,966 |
| Clobetasol Propionate | 33 | $2,044 |
| Clindamycin Phosphate | 55 | $1,447 |
| Metronidazole | 24 | $1,385 |
| Minocycline Hcl | 67 | $1,181 |
| Ketoconazole | 55 | $1,107 |
| Alclometasone Dipropionate | 29 | $1,000 |
| Doxycycline Hyclate | 56 | $932 |
| Mometasone Furoate | 33 | $727 |
| Mupirocin | 117 | $593 |
| Imiquimod | 26 | $554 |
| Ciclopirox | 16 | $547 |
| ValacyclovirValacyclovir Hcl | 39 | $524 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Hays
- Tara GillespieHays$5K
- Gary GrafTopeka$726K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.